Pitcairn Wealth Advisors LLC

Position in ALNY — Alnylam Pharmaceuticals, Inc.

CIK 2089089 CONSHOHOCKEN, PA

Position in ALNY

as of Jun 30, 2026 · filed Aug 10, 2026 Compact

Position Value

$275,141

New position

Shares Held

914

first reported quarter

Ownership

0.001%

of shares outstanding

% of Portfolio

0.07%

of 13F equity value

Holder Rank

#556

of 784 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Pitcairn Wealth Advisors LLC holds $1,686,644 across 3 Biotechnology names. ALNY ranks #3 (16.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AXSM	Axsome Therapeutics, Inc.	3,074	$752,422
2	REGN	Regeneron Pharmaceuticals, Inc.	1,057	$659,081
3	ALNY	Alnylam Pharmaceuticals, Inc. This page	914	$275,141

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$275,141	914	—	Shares	Sole	2026-08-10
No filing history on record for this holder in this stock.